Details

Autor(en) / Beteiligte

• Pittet, Laure F.
• Tebruegge, Marc
• Dutta, Binita
• Donath, Susan
• Messina, Nicole
• Casalaz, Dan
• Hanekom, Willem A.
• Britton, Warwick J.
• Robins-Browne, Roy
• Curtis, Nigel
• Ritz, Nicole

Titel

Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guérin (BCG) vaccine

Ist Teil von

• Vaccine, 2021-01, Vol.39 (4), p.652-657

Ort / Verlag

Netherlands: Elsevier Ltd

Erscheinungsjahr

2021

Link zum Volltext

Quelle

Elsevier ScienceDirect Journals Complete

Beschreibungen/Notizen

• •Infant BCG immunisation induces M. ulcerans-specific immune responses.•M. ulcerans- and M. tuberculosis-specific immune responses are qualitatively similar.•Magnitude of M. ulcerans-specific immune responses was not influenced by BCG strain.•These in-vitro findings support the protective effect observed epidemiologically. Bacillus Calmette–Guérin (BCG) vaccine provides partial protection against Buruli ulcer caused by Mycobacterium ulcerans in epidemiological studies. This study aimed to quantify M. ulcerans-specific immune responses induced by BCG immunisation. Intracellular cytokine analysis of in-vitro experiments done 10 weeks after BCG immunisation in 130 Australian infants randomised to one of three BCG vaccine strains given either at birth (BCG-Denmark, BCG-Japan, or BCG-Russia) or at two months of age (BCG-Denmark). Proportions of polyfunctional CD4+ T-cells were higher in M. ulcerans-stimulated compared to unstimulated control samples. These proportions were not influenced by the vaccine strain or timing of the immunisation. The M. ulcerans-specific immune responses showed similar patterns to those observed in M. tuberculosis-stimulated samples, although they were of lower magnitude. Our data show that BCG immunisation induces M. ulcerans-specific immune responses in infants, likely explaining the cross-protective effect observed in epidemiological studies. (ACTRN12608000227392)